FOXD3 and breast carcinoma: Moreover, FoxD3-AS1 has been proposed to serve as a novel tumor promoter in the development and progression of breast cancer by enhancing cell proliferation, migration, invasion and tamoxifen (TMX) resistance (29, 30).